
Ranbaxy Laboratories Ltd, India’s top drugmaker by sales, said its Moroccan unit has started functioning, giving it direct access to a $1 billion pharmaceuticals market. The unit, Ranbaxy’s third in Africa, will also help the company supply products to other north African countries in future, it said on Monday. Ranbaxy’s Africa sales rose 23 per cent to $189 million in 2011, it had said last month. The drugmaker, majority owned by Japan’s Daiichi Sankyo, has sales staff of about 1,000 in 44 African countries and makes drugs in Nigeria and South Africa.
GMT 17:56 2018 Wednesday ,17 January
Ericsson to write down 1.4 billion euros in fourth quarterGMT 19:16 2018 Saturday ,13 January
China shuts Marriott website over Tibet error, scolds other firmsGMT 17:31 2018 Thursday ,11 January
UK group bids for Europe's biggest aluminium smelterGMT 17:24 2018 Thursday ,11 January
UK supermarket Sainsbury's lifts outlook after bumper ChristmasGMT 17:52 2018 Tuesday ,09 January
H&M removes 'black boy' ad after racism accusationGMT 19:38 2018 Wednesday ,03 January
Petrobras pay $2.95bn to settle US class action on corruptionGMT 13:49 2018 Wednesday ,03 January
China’s Ant Financial drops $1.2 billion MoneyGram deal as US approval failsGMT 17:47 2017 Sunday ,31 December
BA owner to buy bankrupt Austrian airline Niki
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor